- Home
- NKTR vs HEQ Comparison
NKTR vs HEQ Comparison
Compare NKTR & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- HEQ
- Stock Information
- Founded
- NKTR 1990
- HEQ 2011
- Country
- NKTR United States
- HEQ United States
- Employees
- NKTR N/A
- HEQ N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- HEQ Investment Managers
- Sector
- NKTR Health Care
- HEQ Finance
- Exchange
- NKTR Nasdaq
- HEQ Nasdaq
- Market Cap
- NKTR 108.3M
- HEQ 127.0M
- IPO Year
- NKTR 1994
- HEQ N/A
- Fundamental
- Price
- NKTR $22.72
- HEQ $10.62
- Analyst Decision
- NKTR Strong Buy
- HEQ
- Analyst Count
- NKTR 6
- HEQ 0
- Target Price
- NKTR $77.50
- HEQ N/A
- AVG Volume (30 Days)
- NKTR 4.6M
- HEQ 43.1K
- Earning Date
- NKTR 08-07-2025
- HEQ 01-01-0001
- Dividend Yield
- NKTR N/A
- HEQ 9.78%
- EPS Growth
- NKTR N/A
- HEQ N/A
- EPS
- NKTR N/A
- HEQ N/A
- Revenue
- NKTR $87,248,000.00
- HEQ N/A
- Revenue This Year
- NKTR N/A
- HEQ N/A
- Revenue Next Year
- NKTR N/A
- HEQ N/A
- P/E Ratio
- NKTR N/A
- HEQ N/A
- Revenue Growth
- NKTR N/A
- HEQ N/A
- 52 Week Low
- NKTR $6.48
- HEQ $9.08
- 52 Week High
- NKTR $37.38
- HEQ $11.84
- Technical
- Relative Strength Index (RSI)
- NKTR 61.91
- HEQ 56.55
- Support Level
- NKTR $22.09
- HEQ $10.45
- Resistance Level
- NKTR $26.59
- HEQ $10.73
- Average True Range (ATR)
- NKTR 3.79
- HEQ 0.08
- MACD
- NKTR 0.46
- HEQ 0.01
- Stochastic Oscillator
- NKTR 49.62
- HEQ 69.44
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.